Raymond James lowered the firm’s price target on Integral Ad Science (IAS) to $11 from $13 and keeps an Outperform rating on the shares. The company beat expectations for Q2 and posted “solid” Q3 guidance that points to continued momentum, the analyst tells investors in a research note. If the company can continue these trends and avoid the one-off issues that have popped up periodically over the last few quarters, it would go a long way toward restoring confidence in the “stability” narrative, the firm argues.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IAS:
- Integral Ad Science price target raised to $10 from $9 at Barclays
- Integral Ad Science Reports Strong Q2 2025 Growth
- Integral Ad Science reports Q2 EPS 10c, consensus 17c
- Integral Ad Science sees Q3 revenue $148M-$150M, consensus $148.18M
- Integral Ad Science sees 2025 revenue $597M-$605M, consensus $595.61M